Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $790.93 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $203.90 | 9 | $0 (2024) |
| Amgen Inc. | $107.20 | 7 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $96.08 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $73.06 | 4 | $0 (2023) |
| Lilly USA, LLC | $47.65 | 3 | $0 (2021) |
| Corcept Therapeutics | $38.70 | 2 | $0 (2023) |
| PFIZER INC. | $35.62 | 2 | $0 (2024) |
| Esperion Therapeutics, Inc. | $34.45 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $27.50 | 2 | $0 (2024) |
| Genentech USA, Inc. | $20.87 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.79 | 4 | PFIZER INC. ($35.62) |
| 2023 | $264.68 | 15 | ABBVIE INC. ($66.83) |
| 2022 | $199.91 | 12 | ABBVIE INC. ($65.86) |
| 2021 | $242.55 | 20 | Amgen Inc. ($59.84) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: PAIN | ||||||
| 07/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: PAIN | ||||||
| 04/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Respiratory | ||||||
| 11/29/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Endocrinology | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Bone Health | ||||||
| 10/31/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Neuroscience | ||||||
| 10/18/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Biological | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Bone Health | ||||||
| 07/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Inflammation | ||||||
| 06/28/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: DIABETES | ||||||
| 03/15/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Endocrinology | ||||||
| 02/02/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: DIABETES | ||||||
| 10/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2022 | Covis Pharma GmBH | ALVESCO (Drug), TUDORZA PRESSAIR | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Respiratory | ||||||
| 08/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: DIABETES | ||||||
| 05/31/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: DIABETES | ||||||
| 05/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2022 | Metacel Pharmaceuticals LLC | Ozobax (Drug) | Food and Beverage | Cash or cash equivalent | $12.18 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 504 | 806 | $37,610 | $8,636 |
| 2022 | 19 | 538 | 769 | $34,749 | $8,519 |
| 2021 | 17 | 620 | 880 | $40,364 | $9,296 |
| 2020 | 15 | 558 | 746 | $34,875 | $8,208 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 71 | 136 | $8,840 | $1,408 | 15.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 73 | 142 | $4,970 | $1,081 | 21.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 48 | 71 | $5,325 | $931.52 | 17.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 46 | 96 | $4,800 | $913.92 | 19.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 27 | 55 | $1,100 | $892.10 | 81.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 39 | 54 | $3,402 | $888.84 | 26.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 36 | 39 | $1,365 | $631.80 | 46.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 21 | 29 | $1,450 | $428.62 | 29.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 31 | 44 | $1,672 | $388.96 | 23.3% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 18 | 23 | $1,311 | $307.28 | 23.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 20 | 21 | $945.00 | $235.02 | 24.9% |
| 83540 | Iron level | Office | 2023 | 18 | 24 | $672.00 | $152.16 | 22.6% |
| 83735 | Magnesium level | Office | 2023 | 16 | 22 | $308.00 | $144.54 | 46.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 14 | 15 | $750.00 | $124.35 | 16.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 26 | 35 | $700.00 | $108.85 | 15.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 60 | 97 | $6,305 | $1,012 | 16.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 70 | 120 | $4,200 | $921.76 | 21.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 42 | 87 | $4,350 | $834.40 | 19.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 26 | 51 | $1,020 | $832.50 | 81.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 40 | 50 | $3,150 | $830.65 | 26.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 41 | 56 | $4,200 | $741.54 | 17.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 40 | 44 | $1,540 | $719.05 | 46.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 25 | 29 | $1,450 | $432.52 | 29.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 12 | $600.00 | $418.65 | 69.8% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 17 | 22 | $1,254 | $296.73 | 23.7% |
About Beverly Neace, PAC
Beverly Neace, PAC is a Physician Assistant healthcare provider based in Hazard, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013911346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beverly Neace, PAC has received a total of $790.93 in payments from pharmaceutical and medical device companies, with $83.79 received in 2024. These payments were reported across 51 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($790.93).
As a Medicare-enrolled provider, Neace has provided services to 2,220 Medicare beneficiaries, totaling 3,201 services with total Medicare billing of $34,659. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Hazard, KY
- Active Since 05/23/2005
- Last Updated 02/13/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1013911346
Products in Payments
- QULIPTA (Drug) $154.29
- JARDIANCE (Drug) $96.08
- TRELEGY ELLIPTA (Drug) $73.06
- Otezla (Drug) $61.73
- NURTEC ODT (Drug) $53.17
- Korlym (Drug) $38.70
- UBRELVY (Drug) $36.28
- NEXLIZET (Drug) $34.45
- TRULICITY (Drug) $32.38
- EVENITY (Biological) $30.93
- Xofluza (Drug) $20.87
- INVEGA SUSTENNA (Drug) $17.73
- Ozempic (Drug) $16.70
- EMGALITY (Drug) $15.27
- ALVESCO (Drug) $15.16
- Aimovig (Biological) $14.54
- BREZTRI (Drug) $14.26
- Veozah (Drug) $14.21
- VIBERZI (Drug) $13.33
- AIRSUPRA (Drug) $13.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Hazard
Marty Mullins, Pa, PA
Physician Assistant — Payments: $55,641
Terry Smith, Pac, PAC
Physician Assistant — Payments: $7,851
Crystal Gibson, Pa C, PA C
Physician Assistant — Payments: $6,189
Sherry Miller, Pa, PA
Physician Assistant — Payments: $4,442
Kelly Goins, Pa-C, PA-C
Physician Assistant — Payments: $630.91
Sabrina Castle, Pa-C, PA-C
Physician Assistant — Payments: $360.66